Literature DB >> 6747664

The location of neuromuscular junctions on regenerating adult mouse muscle in culture.

M Ecob.   

Abstract

The location of neuromuscular junctions which form in vitro between regenerating adult mouse muscle fibres and sections of embryonic mouse spinal cord was examined. The position of the original motor end-plates on the explanted muscle fibres was determined by using either rhodamine-labelled alpha-bungarotoxin (R alpha BT) binding to the acetylcholine receptors, or by stains to demonstrate acetylcholinesterase (AChE) also located at the end-plate. In this culture system, the explanted muscle fibres degenerate and regenerate to form new myotubes which develop cross-striations and contractions. The location of the newly-formed neuromuscular junctions in these mature cultures was then demonstrated using R alpha BT-binding to acetylcholine receptors, silver impregnation and cholinesterase techniques. Less than half the new neuromuscular junctions were at the original end-plate areas indicating that, at least in this system, junctions can form at sites other than those of the original end-plate.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6747664     DOI: 10.1016/0022-510x(84)90035-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Functional evaluation of nerve-skeletal muscle constructs engineered in vitro.

Authors:  Lisa M Larkin; Jack H Van der Meulen; Robert G Dennis; Jeffrey B Kennedy
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Mar-Apr       Impact factor: 2.416

2.  Implantation of autologous cells in minced and devitalized rat skeletal muscles.

Authors:  E Ghins; M Colson-Van Schoor; G Marechal
Journal:  J Muscle Res Cell Motil       Date:  1986-04       Impact factor: 2.698

3.  Neonatal and adult myosin heavy chain isoforms in a nerve-muscle culture system.

Authors:  M S Ecob-Prince; M Jenkison; G S Butler-Browne; R G Whalen
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.